Menopause is often framed as something that happens quietly in your 50s, after kids are grown and life has “settled.” But for ...

Helping women navigate their menopause is a significant part of a GP's workload: around one third of the female population in the UK, an estimated 13 million, is perimenopausal or menopausal. NICE ...

Panelists discuss how innovative neurokinin-targeted therapies for vasomotor symptoms can reshape menopause management and address unmet needs and improving patient outcomes while highlighting the ...

Menopause is a normal physiological milestone marking the end of a woman's reproductive years. While it is universal, the experience of menopause is deeply personal and highly variable. Some people ...

Research shows that up to 70% of women experience significant mood changes during menopause, yet many feel completely unprepared for the emotional roller coaster. Women might expect hot flashes and ...

Menopause is a natural and sometimes burdensome part of life. However, specific foods may help ease menopause symptoms so you can feel your best during menopause.

The transformation of menopause marks a significant chapter in women’s lives, typically emerging between ages 45 and 55. As millions of women navigate this natural transition each year, understanding ...

Sleep disturbances in menopause are independent symptoms, impacting mood, cardiovascular health, and Alzheimer's risk. Elinzanetant may improve sleep quality in menopausal women, addressing a critical ...

During the multiyear transition to menopause, women's bodies begin processing sugar and carbs less efficiently, while their ...

In this section, we provide a brief overview of coordinated (ie, multidisciplinary and interprofessional) management of menopause. The first section explains why a coordinated effort of different ...

Menopause represents a profound systemic shift involving cardiovascular, skeletal, and neurological health, requiring tailored clinical intervention.

Use of MHT following menopause is not associated with an increased risk for breast cancer among BRCA1 and BRCA2 carriers.